nps 1506 has been researched along with Apoplexy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artman, LD; Balandrin, MF; Brady, E; Chien, Y; Delmar, EG; George, K; Kierstead, A; Marriott, TB; Moe, ST; Mueller, AL; Newman, MK; Raszkiewicz, JL; Sanguinetti, EL; van Wagenen, BC; Wells, D | 1 |
1 review(s) available for nps 1506 and Apoplexy
| Article | Year |
|---|---|
NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies.
Topics: Adolescent; Adult; Animals; Brain Ischemia; Clinical Trials as Topic; Drug Evaluation, Preclinical; Fluorobenzenes; Humans; Learning; Male; Neuroprotective Agents; Propylamines; Receptors, N-Methyl-D-Aspartate; Stroke | 1999 |